Phospho-CDC6 (S54) Antibody

What is the biological significance of CDC6 phosphorylation at Ser54?

CDC6 phosphorylation at Ser54 plays a crucial role in chromatin binding during DNA replication. Unlike other phosphorylation sites, Ser54-phosphorylated CDC6 maintains a high affinity for chromatin during S phase, indicating its specific function in DNA replication regulation . This phosphorylation is performed by cyclin E/CDK2 and cyclin A/CDK2 complexes, highlighting its cell cycle-dependent nature . The specific phosphorylation of Ser54 helps ensure the proper loading of pre-replication complexes onto DNA, a critical step in genome duplication.

Experimental evidence from multiple studies confirms that while some phosphorylated forms of CDC6 are translocated to the cytosol, the chromatin-bound Ser54-phosphorylated CDC6 persists through S and G2 phases . This selective retention demonstrates the specialized function of this specific phosphorylation site in maintaining genomic integrity.

How does CDC6 phosphorylation relate to cell cycle progression?

CDC6 phosphorylation exhibits distinct patterns throughout the cell cycle:

The protein is predominantly nuclear in G1 phase cells and becomes partially cytoplasmic during S-phase . This translocation is regulated by phosphorylation status, with Ser54-phosphorylated CDC6 specifically maintaining chromatin association . This dynamic regulation ensures that DNA replication occurs once and only once per cell cycle, preventing genomic instability.

What are the optimal conditions for detecting Phospho-CDC6 (S54) using Western blot?

For optimal Western blot detection of Phospho-CDC6 (S54):

• Sample preparation: Extract total protein from cells in exponential growth phase to capture active cell cycle progression

• Protein amount: Load 20-40 μg of total protein per lane

• Antibody dilution: Use anti-Phospho-CDC6 (S54) antibody at 1:1,000-1:2,000 dilution

• Secondary antibody: HRP-conjugated anti-rabbit IgG

• Controls: Include both phosphatase-treated negative controls and CDK2-activated positive controls

• Expected band: ~63 kDa (calculated MW: 62720 Da)

• Normalization: Probe parallel blots for total CDC6 protein to calculate phosphorylation ratio

Western blot analysis has successfully detected Phospho-CDC6 (S54) in Jurkat cell lysates at the recommended dilution . Ensure preservation of phosphorylation status by including phosphatase inhibitors in all buffers during sample preparation.

What are the recommended protocols for immunocytochemistry with Phospho-CDC6 (S54) antibody?

For immunocytochemistry applications:

• Cell preparation:

  • Culture cells on glass coverslips

  • Fix cells with 4% paraformaldehyde (10 minutes at room temperature)

  • Permeabilize with 0.25% Triton X-100/PBS (10 minutes)

• Antibody incubation:

  • Block with 1-5% BSA in PBS (1 hour at room temperature)

  • Primary antibody dilution: 1:50-1:200 for ICC applications

  • Incubate overnight at 4°C

  • Wash 3x with PBS

  • Incubate with fluorophore-conjugated secondary antibody (1-2 hours at room temperature)

  • Counterstain nuclei with DAPI

• Visualization parameters:

  • Phospho-CDC6 (S54) typically shows nuclear localization in G1 phase

  • During S phase, observe both nuclear and cytoplasmic distribution

  • Use high-resolution confocal microscopy for co-localization studies

Successful ICC staining of Phospho-CDC6 (S54) has been demonstrated in HeLa cells, with the signal appearing primarily in green when using appropriate fluorophore-conjugated secondary antibodies, while nuclear counterstaining with DAPI appears blue .

How can researchers differentiate between chromatin-bound and soluble Phospho-CDC6 (S54)?

Distinguishing between chromatin-bound and soluble pools of Phospho-CDC6 (S54) requires specialized fractionation techniques:

• Sequential extraction method:

  • Harvest cells and wash in ice-cold PBS

  • Extract cytoplasmic fraction using hypotonic buffer with 0.1% Triton X-100

  • Extract nucleoplasmic fraction using nuclear extraction buffer

  • Isolate chromatin fraction by resuspending pellet in high-salt buffer (>300mM NaCl)

  • Analyze fractions by Western blot using Phospho-CDC6 (S54) antibody

• Immunofluorescence approach:

  • Pre-extract cells with CSK buffer (10mM PIPES pH 6.8, 100mM NaCl, 300mM sucrose, 3mM MgCl₂, 1mM EGTA, 0.5% Triton X-100) before fixation

  • This removes soluble proteins while retaining chromatin-bound proteins

  • Fix remaining structures and perform standard immunofluorescence

  • Compare with non-extracted cells to determine relative distribution

Research has demonstrated that Ser54-phosphorylated CDC6 specifically maintains high affinity for chromatin during S phase, while other forms may be more readily detected in soluble fractions . This methodological distinction is crucial for understanding the compartmentalization of CDC6 function during cell cycle progression.

What are the challenges in studying CDK2-dependent phosphorylation of CDC6 at Ser54?

Studying CDK2-dependent phosphorylation of CDC6 at Ser54 presents several technical challenges:

• Temporal dynamics:

  • CDC6 phosphorylation status changes rapidly during cell cycle

  • Requires precise cell synchronization methods

  • Consider nocodazole block-and-release or double thymidine block for synchronization

• Phosphorylation specificity:

  • CDC6 contains multiple phosphorylation sites (Ser54, Ser74, Ser106)

  • Use of phospho-specific antibodies is essential

  • Consider phospho-mimetic (S→D) and phospho-deficient (S→A) mutants for functional studies

• CDK2 specificity:

  • CDK2 inhibitors like roscovitine affect multiple cellular targets

  • Correlate CDK2 activity measurement with CDC6 phosphorylation status

  • Consider RNA interference or CRISPR approaches for more specific CDK2 targeting

• Experimental validation:

  • In vitro kinase assays with purified CDK2/cyclin complexes and CDC6 substrates

  • Mass spectrometry to confirm phosphorylation sites

  • Functional assays to assess biological consequences of phosphorylation status

Research has shown that CDC6 protein stability is directly linked to CDK2 activity, as treatment with roscovitine (CDK2 inhibitor) results in rapid reduction of CDC6 levels . This connection should be considered when designing experiments to study this specific phosphorylation.

How can researchers quantitatively measure Phospho-CDC6 (S54) levels in cell populations?

For quantitative assessment of Phospho-CDC6 (S54) levels:

• Cell-Based ELISA technique:

  • Plate cells in 96-well microplates

  • Fix and permeabilize cells

  • Incubate with Anti-Phospho-CDC6 (S54) antibody

  • Detect using HRP-conjugated secondary antibody

  • Normalize results to cell number using crystal violet staining

• Flow cytometry approach:

  • Fix cells with paraformaldehyde

  • Permeabilize with methanol or Triton X-100

  • Stain with fluorophore-conjugated Anti-Phospho-CDC6 (S54) antibody

  • Co-stain with DNA content marker (PI or DAPI)

  • Analyze correlation between phosphorylation status and cell cycle phase

• Quantitative Western blot:

  • Use fluorescent secondary antibodies instead of HRP

  • Include standard curve with known amounts of phosphorylated protein

  • Analyze band intensity with software like ImageJ

  • Calculate phospho:total CDC6 ratio

For cell-based assays, remember that Phospho-CDC6 (S54) signals will vary throughout the cell cycle, so consider cell synchronization or co-staining with cell cycle markers for more meaningful analysis .

What controls should be included when validating Phospho-CDC6 (S54) antibody specificity?

Proper validation of Phospho-CDC6 (S54) antibody specificity requires rigorous controls:

• Positive controls:

  • Treatment with CDK2 activators (e.g., growth factors in serum-starved cells)

  • S-phase synchronized cells (when Ser54 phosphorylation peaks)

  • Cells expressing constitutively active CDK2 constructs

  • Recombinant phosphorylated CDC6 protein (for Western blot)

• Negative controls:

  • CDC6 knockdown or knockout cells

  • λ-phosphatase-treated samples

  • CDK2 inhibition with roscovitine

  • Phospho-deficient CDC6 mutant (S54A)

• Specificity controls:

  • Peptide competition assays using the phospho-peptide immunogen

  • Cross-reactivity assessment with other phosphorylated proteins

  • Comparison with alternative Phospho-CDC6 (S54) antibodies from different vendors

  • Multi-technique validation (e.g., WB, ICC, and IP with the same antibody)

A comprehensive validation should demonstrate that the antibody signal increases with CDK2 activation and decreases with CDK2 inhibition, and should be abolished by phosphatase treatment or peptide competition .

How does p53 activation affect CDC6 Ser54 phosphorylation status?

The relationship between p53 activation and CDC6 Ser54 phosphorylation involves complex regulatory mechanisms:

• Direct mechanisms:

  • p53 activation induces p21^cip1 expression

  • p21^cip1 inhibits CDK2 activity

  • Reduced CDK2 activity leads to decreased CDC6 Ser54 phosphorylation

  • This mechanism contributes to cell cycle arrest following DNA damage

• Experimental evidence:

  • Ionizing radiation (IR) treatment of MCF-7 cells (with functional p53) shows:

    • Reduction in CDC6 protein levels

    • Decreased CDK2 activity

    • Correlation between these two events

• Methodological approach to study this relationship:

  • Compare p53-proficient and p53-deficient cell lines

  • Induce p53 using non-genotoxic activators (e.g., Nutlin-3)

  • Monitor CDC6 Ser54 phosphorylation by Western blot

  • Perform kinase assays to measure CDK2 activity

  • Use time-course experiments to establish causality

This p53-dependent regulation represents an important checkpoint mechanism, ensuring that cells with DNA damage do not initiate DNA replication, which would propagate genomic instability .

What is the relationship between chromatin-bound Phospho-CDC6 (S54) and DNA replication licensing?

The specific relationship between chromatin-bound Phospho-CDC6 (S54) and DNA replication licensing involves several coordinated molecular events:

• Temporal dynamics:

  • CDC6 loads onto chromatin during late mitosis/early G1

  • Phosphorylation at Ser54 occurs as cells approach S phase

  • Phosphorylated CDC6 remains chromatin-bound during replication

• Functional implications:

  • Ser54 phosphorylation stabilizes CDC6 on chromatin

  • This stabilization is essential for maintaining origin licensing during replication

  • Prevents re-licensing of already-replicated DNA

  • Contributes to genome stability mechanisms

• Experimental approach to study this relationship:

  • Chromatin immunoprecipitation (ChIP) using Phospho-CDC6 (S54) antibody

  • Proximity ligation assay (PLA) between Phospho-CDC6 (S54) and other replication factors

  • FRAP (Fluorescence Recovery After Photobleaching) to measure dynamics of wild-type vs. S54A mutant CDC6

  • Correlation between origin firing and Phospho-CDC6 (S54) chromatin binding

These sophisticated methodologies allow researchers to distinguish between cause and correlation in the relationship between CDC6 phosphorylation and replication licensing control.

What are common issues when detecting Phospho-CDC6 (S54) and how can they be resolved?

Researchers frequently encounter several challenges when working with Phospho-CDC6 (S54) antibodies:

• Weak or absent signal:

  • Ensure phosphatase inhibitors are fresh and included in all buffers

  • Try shorter fixation times (overfixation can mask epitopes)

  • Optimize antibody concentration (try 1:500 to 1:2000 range)

  • Include positive controls (S-phase synchronized cells)

  • Consider antigen retrieval methods for fixed tissues

• High background:

  • Increase blocking time and concentration (5% BSA or milk for 2 hours)

  • Reduce primary antibody concentration

  • Ensure secondary antibody is compatible with primary

  • Include additional washing steps with 0.1% Tween-20

  • Pre-absorb antibody with non-specific proteins

• Non-specific bands in Western blot:

  • Increase gel percentage for better resolution around 63 kDa

  • Use freshly prepared samples to avoid degradation

  • Consider gradient gels for improved separation

  • Perform peptide competition controls

• Inconsistent results between experiments:

  • Standardize cell synchronization protocols

  • Control for cell density effects on cell cycle distribution

  • Establish fixed timepoints relative to synchronization release

  • Prepare master mixes of antibody dilutions

Proper storage of the antibody at -20°C for long-term and 4°C for up to one month will help maintain consistent reactivity . Avoid repeated freeze-thaw cycles that can degrade antibody quality.

How can researchers optimize immunohistochemistry protocols for Phospho-CDC6 (S54) in tissue samples?

Optimizing IHC protocols for Phospho-CDC6 (S54) in tissue samples requires special considerations:

• Tissue fixation and processing:

  • Limit fixation time in formalin (12-24 hours optimal)

  • Use phosphate buffers without phosphatases during processing

  • Consider preparing fresh frozen sections for phospho-epitope preservation

• Antigen retrieval methods:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0)

  • Try alternative retrieval buffers (EDTA, pH 8.0) if citrate is ineffective

  • Optimize retrieval time (10-30 minutes)

• Detection optimization:

  • Use signal amplification systems (TSA, polymer-based detection)

  • Apply primary antibody at 1:50-1:100 dilution

  • Extend primary antibody incubation to overnight at 4°C

  • Include sequential phosphatase inhibitors in all steps

• Controls for tissue IHC:

  • Include proliferative tissues (intestinal crypts, germinal centers) as positive controls

  • Pre-treat control sections with lambda phosphatase

  • Perform dual staining with proliferation markers (Ki-67, PCNA)

  • Compare with patterns of total CDC6 staining

Immunohistochemistry has been successfully performed on formalin-fixed, paraffin-embedded human cancer tissues, including breast carcinoma and hepatocarcinoma, demonstrating the feasibility of this technique with proper optimization .

How do different detection methods for Phospho-CDC6 (S54) compare in sensitivity and specificity?

Various methods for detecting Phospho-CDC6 (S54) offer different advantages and limitations:

For western blotting applications, researchers have successfully detected Phospho-CDC6 (S54) in Jurkat cell lysates using 1:1,000 dilution . Immunocytochemistry has shown effective staining in HeLa cells with distinct nuclear localization patterns . Cell-based ELISA systems offer high-throughput capabilities for screening multiple conditions simultaneously .

The choice of method should be determined by the specific research question, with western blotting providing good specificity for validation, while imaging techniques offer spatial information about subcellular localization.

What are the latest advanced techniques for studying Phospho-CDC6 (S54) dynamics in living cells?

Cutting-edge approaches for studying Phospho-CDC6 (S54) dynamics in living systems include:

• FRET-based biosensors:

  • Design: CDC6 protein flanked by fluorophore pair

  • Phosphorylation induces conformational change detectable by FRET

  • Enables real-time visualization of phosphorylation status

  • Can be targeted to specific subcellular compartments

• Optogenetic approaches:

  • Light-inducible CDK2 activation systems

  • Temporal and spatial control of CDC6 phosphorylation

  • Combine with live-cell imaging of fluorescently-tagged CDC6

  • Measure phosphorylation dynamics with phospho-specific antibodies post-fixation

• Advanced microscopy:

  • Super-resolution techniques (STORM, PALM) for nanoscale localization

  • Lattice light-sheet microscopy for 3D visualization with reduced phototoxicity

  • Single-molecule tracking to follow individual CDC6 molecules

  • Correlative light-electron microscopy to combine functional and structural data

• Engineered cellular models:

  • CRISPR knock-in of fluorescent tags at endogenous CDC6 locus

  • Auxin-inducible degron systems for rapid CDC6 depletion

  • Phospho-mimetic and phospho-deficient mutations at Ser54

  • Inducible expression systems for temporal control

These advanced techniques allow researchers to move beyond static snapshots of CDC6 phosphorylation to understand the dynamic regulation of this protein throughout the cell cycle and its response to various cellular stresses.